It uses TNM information based on the patientâ€™s history, physical examination, imaging results (not required for clinical staging), and biopsies.
The Pathological Prognostic Stage applies to patients with invasive breast cancer initially treated with surgery.
It includes all information used for clinical staging, surgical findings, and pathological findings following surgery to remove the tumor.
Pathological Prognostic Stage is not used for patients treated with neoadjuvant therapy before surgery to remove the tumor.[3] Barnes DM, Harris WH, Smith P, et al.: Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients.